Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NantHealth, Inc.NH · Entity 109592 | Director | June 16, 2021 | July 26, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NantHealth, Inc.
Report date June 16, 2021 · Filed July 26, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.65 · Expires 2031-06-16 | Direct | 100,000 |
Reported balance
After 2021-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-16 · Grant · Acquired 100,000 · Balance 100,000 F1: The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
JAKKS PACIFIC INC
Report date August 09, 2019 · Filed September 18, 2019 · Amendment
Section 16 reporting ended · disclosed 2019-09-18. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 174,246 |
Reported balance
After 2019-08-09 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2019-08-09 · Disposition to issuer · Disposed 13,676 · Balance 174,246 F1: Represents the forfeiture of 13,676 unvested shares under the Company's 2002 Stock Award and Incentive Plan as of the closing date of the transaction agreement previously disclosed by the Company. F2: Represents the average closing price of the Company's common stock for the ten trading days preceding the date of grant, as reported by NASDAQ. F3: Includes 41,029 shares accelerated under the Company's 2002 Stock Award and Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the forfeiture of 13,676 unvested shares under the Company's 2002 Stock Award and Incentive Plan as of the closing date of the transaction agreement previously disclosed by the Company.
F2: Represents the average closing price of the Company's common stock for the ten trading days preceding the date of grant, as reported by NASDAQ.
F3: Includes 41,029 shares accelerated under the Company's 2002 Stock Award and Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2021 Filed Jul 26, 2021 17:56 UTC | NantHealth, Inc. NH · Entity 109592 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000899243-21-029920 · doc4.xml · derivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-06-16 F1 · derivative.exercise_date: The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date. Read SEC document |
| May 21, 2020 Filed May 26, 2020 17:19 UTC | NantHealth, Inc. NH · Entity 109592 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0000899243-20-014203 · doc4.xml · derivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-05-21 F1 · derivative.exercise_date: The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date. Read SEC document |
| August 09, 2019 Filed Aug 14, 2019 00:06 UTC | JAKKS PACIFIC INC JAKK · Entity 6006 | Disposition to issuerCommon Stock | 13,676 | $1.83 | $25,027.08 |
DisclosureSEC source: 0001628280-19-010713 · wf-form4_156574116476958.xml · nonDerivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,951 F1 · shares: Represents the forfeiture of 13,676 unvested shares under the Company's 2002 Stock Award and Incentive Plan as of the closing date of the transaction agreement previously disclosed by the Company. F2 · price: Represents the average closing price of the Company's common stock for the ten trading days preceding the date of grant, as reported by NASDAQ. F3 · balance_after: Includes 41,029 shares accelerated under the Company's 2002 Stock Award and Incentive Plan. Read SEC document |
| August 09, 2019 Filed Sep 18, 2019 23:10 UTC Amendment | JAKKS PACIFIC INC JAKK · Entity 6006 | Disposition to issuerCommon Stock | 13,676 | $1.83 | $25,027.08 |
DisclosureSEC source: 0001144204-19-045114 · tv529728_form4a.xml · nonDerivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,246 F1 · shares: Represents the forfeiture of 13,676 unvested shares under the Company's 2002 Stock Award and Incentive Plan as of the closing date of the transaction agreement previously disclosed by the Company. F2 · price: Represents the average closing price of the Company's common stock for the ten trading days preceding the date of grant, as reported by NASDAQ. F3 · balance_after: Includes 41,029 shares accelerated under the Company's 2002 Stock Award and Incentive Plan. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 19:32 UTC | NantHealth, Inc. NH · Entity 109592 | GrantStock Option (right to buy) · Derivative | 301,908 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0000899243-19-017241 · doc4.xml · derivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,908 Underlying: Common Stock · 301,908 shares Expires 2029-06-13 F1 · derivative.exercise_date: The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:09 UTC | JAKKS PACIFIC INC JAKK · Entity 6006 | GrantCommon Stock | 54,705 | $1.83 | $100,110.15 |
DisclosureSEC source: 0001144204-19-000384 · tv510254_4.xml · nonDerivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,922 F1 · shares: Issued under the Company's 2002 Stock Award and Incentive Plan. In accordance with such Plan, the shares so issued will vest on, and may not be sold, mortgaged, pledged, transferred or otherwise encumbered prior to, January 1, 2020. F2 · price: Represents the average closing price of the Company's common stock for the ten trading days preceding the date of grant, as reported by NASDAQ. F3 · balance_after: Certain of these shares may be restricted from transfer pursuant to the minimum stock ownership provisions adopted by the Company's Board of Directors. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 16:52 UTC | NantHealth, Inc. NH · Entity 109592 | GrantCommon Stock | 52,910 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-024014 · doc4.xml · nonDerivative · entry 2 SITRICK MICHAEL S · CIK 0001371443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,780 F1 · security: Each restricted stock unit ("RSU") is the economic equivalent of one share of NantHealth, Inc. common stock. F3 · shares: The RSUs shall vest on the earlier of (i) the one year anniversary of the date the RSU award is granted, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, in each case, subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through the applicable vesting date. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 16:52 UTC | NantHealth, Inc. NH · Entity 109592 | GrantCommon Stock | 45,002 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-024014 · doc4.xml · nonDerivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,870 F1 · security: Each restricted stock unit ("RSU") is the economic equivalent of one share of NantHealth, Inc. common stock. F2 · shares: Subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through each applicable vesting date, 33,751 RSUs shall be vested as of September 6, 2018, and the remaining 11,251 RSUs shall vest in installments as follows: 3,750 RSUs shall vest on each of December 7, 2018 and March 7, 2019, and 3,751 RSUs shall vest on June 7, 2019. Read SEC document |
| January 01, 2018 Filed Jan 4, 2018 00:11 UTC | JAKKS PACIFIC INC JAKK · Entity 6006 | GrantCommon Stock | 41,580 | $2.41 | $99,999.90 |
DisclosureSEC source: 0001144204-18-000621 · tv482586_form4.xml · nonDerivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,217 F1 · shares: Issued under the Company's 2002 Stock Award and Incentive Plan. In accordance with such Plan, the shares so issued will vest on, and may not be sold, mortgaged, pledged, transferred or otherwise encumbered prior to, January 1, 2019. F2 · price: Represents the average closing price of the Company's common stock for the ten trading days preceding the date of grant, as reported by NASDAQ. F3 · balance_after: Certain of these shares may be restricted from transfer pursuant to the minimum stock ownership provisions adopted by the Company's Board of Directors. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 17:01 UTC | NantHealth, Inc. NH · Entity 109592 | GrantCommon Stock | 50,868 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-025608 · doc4.xml · nonDerivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,868 F1 · security: Each restricted stock unit ("RSU") is the economic equivalent of one share of NantHealth, Inc. common stock. F2 · shares: Subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through each applicable vesting date, 21,195 RSUs shall be vested as of November 6, 2017, and the remaining 29,673 RSUs shall vest in equal installments on each three-month anniversary of the Vesting Commencement Date over a period of twenty-one (21) months after the Vesting Commencement Date (i.e., 4,239 RSUs shall vest on each of December 7, 2017, March 7, 2018, June 7, 2018, September 7, 2018, December 7, 2018, March 7, 2019 and June 7, 2019). Read SEC document |
| August 07, 2017 Filed Aug 7, 2017 22:29 UTC | JAKKS PACIFIC INC JAKK · Entity 6006 | PurchaseCommon Stock | 10,000 | $3.50 | $35,000.00 |
DisclosureSEC source: 0001144204-17-040942 · v472631_4.xml · nonDerivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,637 F1 · balance_after: Certain of these shares may be restricted from transfer pursuant to the minimum stock ownership provisions adopted by the Company's Board of Directors and certain of these shares are subject to vesting conditions. Read SEC document |
| January 01, 2017 Filed Jan 5, 2017 01:20 UTC | JAKKS PACIFIC INC JAKK · Entity 6006 | GrantCommon Stock | 19,324 | $5.17 | $99,905.08 |
DisclosureSEC source: 0001144204-17-000670 · v456219_form4.xml · nonDerivative · entry 1 SITRICK MICHAEL S · CIK 0001371443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,637 F1 · shares: Issued under the Company's 2002 Stock Award and Incentive Plan. In accordance with such Plan, the shares so issued will vest on, and may not be sold, mortgaged, pledged, transferred or otherwise encumbered prior to, January 1, 2018. F2 · price: Represents the average closing price of the Company's common stock for the ten trading days preceding the date of grant, as reported by NASDAQ. F3 · balance_after: Certain of these shares may be restricted from transfer pursuant to the minimum stock ownership provisions adopted by the Company's Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.